10 Barrel Brewing Introduces Pub Cerveza: a New Twist on ‘Cheap Fun.’ Series
May 03, 2024 07:07 ET
|
Tilray Brands, Inc.
Ahead Of Cinco De Mayo, 10 Barrel’s Award-Winning Brew Team Introduces Pub Cerveza, A Traditional Mexican Style Lager
Uniti Group Inc. Reports First Quarter 2024 Results
May 03, 2024 07:05 ET
|
Uniti Group Inc.
Announced Merger with Windstream Creates Premier Insurgent Fiber Provider Updates 2024 Outlook Net Income of $41.3 Million for the First QuarterNet Income of $0.16 Per Diluted Common Share for the...
Shenandoah Telecommunications Company Reports First Quarter 2024 Results
May 03, 2024 07:00 ET
|
Shenandoah Telecommunications Co
EDINBURG, Va., May 03, 2024 (GLOBE NEWSWIRE) -- Shenandoah Telecommunications Company (“Shentel” or the “Company”) (Nasdaq: SHEN) announced first quarter 2024 financial and operating results. ...
Orchard Therapeutics Co-founder and Chief Executive Officer Dr. Bobby Gaspar Named to Inaugural 2024 TIME100 Health List
May 03, 2024 07:00 ET
|
Orchard Therapeutics (Europe) Limited
TOKYO, LONDON and BOSTON, May 03, 2024 (GLOBE NEWSWIRE) -- Orchard Therapeutics, recently acquired by Kyowa Kirin with the goal of accelerating the delivery of new gene therapies to patients around...
GH Research Reports First Quarter 2024 Financial Results and Provides Business Updates
May 03, 2024 07:00 ET
|
GH Research PLC
Phase 2b clinical trial of GH001 in patients with treatment-resistant depression on track for expected completion of double-blind phase in Q3 2024 and of 6-month open-label extension phase in Q1...
Uniti to Merge with Windstream Creating Premier Insurgent Fiber Provider
May 03, 2024 07:00 ET
|
Uniti Group Inc.
Scaled Platform and Differentiated Focus on Tier II and III Markets De-levered Balance Sheet and Cash Flow Generation to Support Growth Additional Value Creation Opportunities Include up to $125...
Rapid Micro Biosystems Reports First Quarter 2024 Financial Results
May 03, 2024 07:00 ET
|
Rapid Micro Biosystems, Inc.
Reports first quarter 2024 total revenue of $5.6 million, representing growth of 11% compared to first quarter 2023 Reaffirms full year 2024 total revenue guidance of at least $27.0 million,...
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 03, 2024 07:00 ET
|
BioCryst Pharmaceuticals, Inc.
RESEARCH TRIANGLE PARK, N.C., May 03, 2024 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the compensation committee of BioCryst’s board of directors granted...
Galera Adopts Limited Duration Stockholder Rights Agreement
May 03, 2024 07:00 ET
|
Galera Therapeutics
MALVERN, Pa., May 03, 2024 (GLOBE NEWSWIRE) -- Galera Therapeutics, Inc. (Nasdaq: GRTX), a biopharmaceutical company focused on developing a pipeline of novel, proprietary therapeutics that have the...
BeyondSpring To Host Virtual R&D Day to Discuss New Plinabulin Development Strategy for Cancer and Updates for SEED Therapeutics
May 03, 2024 07:00 ET
|
BeyondSpring, Inc.
FLORHAM PARK, N.J., May 03, 2024 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: BYSI) (“BeyondSpring” or the “Company”), a clinical-stage global biopharmaceutical company focused on developing...